Showing results (1101-1110 of 1,300) with videos related to

Sort By:
Pageof 130
Genes and Immunity|May 14, 2010
Elucidating the chromosome 9 association with AS; CARD9 is a candidate geneJ J Pointon, D Harvey, T Karaderi, et al.
Annals of the Rheumatic Diseases|November 21, 2008
Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitisD Harvey, J J Pointon, C Sleator, et al.
Brain Injury|February 5, 2009
Long-term effects of rivastigmine capsules in patients with traumatic brain injuryJonathan M Silver, Barbara Koumaras, Xiangyi Meng, et al.
Schizophrenia Research|May 18, 2024
Associations between fearlessness about death and suicidal ideation in individuals with psychosisJennifer Villa, Duncan G Campbell, Emma M Parrish, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 5, 2010
Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrumMargaret M McClure, Philip D Harvey, Marianne Goodman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 17, 2014
Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating ScaleRichard S E Keefe, Vicki G Davis, Nathan B Spagnola, et al.
Psychological Medicine|January 12, 2021
Ecological momentary facial emotion recognition in psychotic disordersColin A Depp, Snigdha Kamarsu, Tess F Filip, et al.
Schizophrenia Research|April 22, 2006
Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based studyAbraham Reichenberg, Mark Weiser, Michael A Rapp, et al.
Nature Chemical Biology|January 8, 2021
Harnessing nanotechnology to expand the toolbox of chemical biologyRyan M Williams, Shi Chen, Rachel E Langenbacher, et al.
Clinical Pharmacology and Therapeutics|January 12, 2017
A Pharmacokinetic and Safety Study of Trebananib, an Fc-Fusion Peptibody, in Patients With Advanced Solid Tumors and Varying Degrees of Renal DysfunctionB Wu, L D Lewis, R D Harvey, et al.
Pageof 130